Skip to content
★ Sign in to follow
PM

Peter M. Kash

Executive
Xtend AI Robotics, Inc.Javelin Pharmaceuticals, IncCapricor Therapeutics, Inc.
Total declarations
8
Companies
3
▲ Purchases (7 ops.)
€18k
▼ Sales (0 ops.)
—

Latest filing published 19 Oct 2026 for Xtend AI Robotics, Inc..

Insider track record

Disclosed buys
7
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
7

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Peter M. Kash: trading record in brief

Peter M. Kash discloses dealings in 3 companies, chiefly Capricor Therapeutics, Inc., Javelin Pharmaceuticals, Inc and Xtend AI Robotics, Inc. In total, 8 filings cover trades dated from 9 June 2006 to 15 October 2026.

Purchases make up the whole of the open-market record (7 purchases, €18k). The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant.

The median purchase comes to €1,509.

On 19 October 2026 came the latest disclosure, a share grant in Xtend AI Robotics, Inc. The latest purchase dates back some time: it was published 6,331 days ago, on 9 July 2009. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Peter M. Kash

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total

8 of 8 declarations